Govt In­vokes Key Clause to Main­tain Stent Out­put

The Economic Times - - Companies: Pursuit Of Profit - Press Trust of In­dia

New Delhi: The gov­ern­ment on Tues­day made it manda­tory for stent mak­ers to main­tain pro­duc­tion and sup­ply of coro­nary stents by in­vok­ing an emer­gency clause un­der drug price con­trol law cit­ing re­ports of short­age in mar­ket. “Af­ter due de­lib­er­a­tions on the cur­rent sit­u­a­tion and al­ter­na­tives avail­able with the govt to re­sume nor­mal sup­ply of coro­nary stents, it was de­cided to in­voke the pow­ers of Sec­tion 3 (i) of DPCO, 2013,” said the depart­ment of phar­ma­ceu­ti­cals in a let­ter to stent mak­ers.

The depart­ment said there have been re­ports of short­age of coro­nary stents in mar­kets/hospi­tals. Last week, the gov­ern­ment had slashed prices of stents by up to 85% by cap­ping them at ₹ 7,260 for bare metal ones and ₹ 29,600 for the drug elut­ing va­ri­ety. Un­der Sec­tion 3 (i) of DPCO, 2013, the gov­ern­ment can reg­u­late dis­tri­bu­tion and di­rect any man­u­fac­turer to in­crease pro­duc­tion and sell prod­ucts.

Un­der the clause, the govt can reg­u­late dis­tri­bu­tion and di­rect any man­u­fac­turer to in­crease pro­duc­tion and sell prod­ucts

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.